Scripps Research team offers insights that could aid development of phage therapies against Mycobacteria The pathogens which ...

Researchers have produced the most detailed image to date of a bacteriophage -- phage for short -- that has allowed them to see for the first time the structural makeup of the part of the phage that ...

Researchers at Pitt have produced the most detailed image to date of a bacteriophage–phage for short–that has allowed them to see for the first time the structural makeup of the part of the phage that ...

Research on the gut microbiome has focused mainly on bacteria, but bacteriophages and fungi play critical roles as well, with significant influences on health and disease.

Researchers at Pitt have produced the most detailed image to date of a bacteriophage–phage for short–that has allowed them to ...

The following is a summary of “Prevalence of Body Dysmorphic Disorder: A Systematic Review and Meta-Analysis,” published in the April 2025 issue of Journal of Cosmetic Dermatology by Pérez-Buenfil et ...

Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today: Canadian Solar CSIQ is a leading manufacturer of solar photovoltaic modules and a provider of solar energy and battery ...

Ceftazidime-avibactam is a β-lactam/β-lactamase inhibitor combination restricted for the treatment of multidrug-resistant infections of Pseudomonas aeruginosa non-susceptible to ceftazidime and ...

Scientists are now looking to bacteriophage - viruses that infect bacteria - and their potential to treat drug-resistant infections. They have begun to look deeper into an intriguing class of large ...

Biliary tract infections (BTI), often linked to structural abnormalities like bile duct stones, pose significant treatment challenges due to drug-resistant bacteria like Pseudomonas aeruginosa. Phage ...

Join Health Canada's Food Additives e-Notice, a free service to stay on top of issued advice as well as regulatory and scientific developments in the area of food additives and processing aids in ...